CytomX Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 7.81 M | $9.22 M | 0.25% | 9.18% |
| BVF INC/IL | 11/14/2024 | 5.23 M | $6.17 M | 0.00% | 6.14% |
| VANGUARD GROUP INC | 11/13/2024 | 5.16 M | $6.09 M | 5.52% | 6.07% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.81 M | $5.70 M | -23.68% | 5.65% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 3.10 M | $3.66 M | 13.65% | 3.64% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 3.02 M | $3.57 M | 100.00% | 3.55% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 3.00 M | $3.54 M | 0.00% | 3.53% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 2.56 M | $3.02 M | 38.74% | 3.01% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.64 M | $1.94 M | 32.75% | 1.93% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.52 M | $1.80 M | 1.09% | 1.79% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 1.25 M | $1.47 M | -18.21% | 1.47% |
| CONGRESS PARK CAPITAL LLC | 10/09/2024 | 1.22 M | $1.43 M | 5.44% | 1.43% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 1.21 M | $1.43 M | -11.89% | 1.42% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.17 M | $1.38 M | 100.00% | 1.37% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.02 M | $1.20 M | -14.20% | 1.19% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 915,000 | $1.08 M | 100.00% | 1.08% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 903,959 | $1.07 M | 57.99% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 803,531 | $948,369 | 4.42% | 0.94% |
| SEI INVESTMENTS CO | 11/12/2024 | 487,902 | $575,724 | 27.48% | 0.57% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 471,468 | $556,332 | -28.78% | 0.55% |
| WOODLINE PARTNERS LP | 11/14/2024 | 393,832 | $464,722 | 100.00% | 0.46% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 356,624 | $420,816 | -3.39% | 0.42% |
| CITADEL ADVISORS LLC | 11/14/2024 | 317,119 | $374,200 | -35.89% | 0.37% |
| FMR LLC | 11/13/2024 | 284,307 | $335,482 | 17.31% | 0.33% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 280,593 | $331,100 | 10.37% | 0.33% |
| STATE STREET CORP | 11/14/2024 | 263,643 | $311,099 | 0.00% | 0.31% |
| FORMIDABLE ASSET MANAGEMENT, LLC | 11/12/2024 | 246,001 | $290,281 | -4.65% | 0.29% |
| TOROSO INVESTMENTS, LLC | 11/25/2024 | 246,001 | $290,281 | -4.65% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 241,982 | $285,539 | 0.00% | 0.28% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 109,000 | $128,620 | 100.00% | 0.13% |
| CREATIVE PLANNING | 10/11/2024 | 107,000 | $126,260 | 0.00% | 0.13% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 88,518 | $104,000 | 100.00% | 0.10% |
| UBS GROUP AG | 11/14/2024 | 69,135 | $81,579 | -1.75% | 0.08% |
| FOREFRONT ANALYTICS, LLC | 11/14/2024 | 59,760 | $70,518 | -6.72% | 0.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 55,108 | $65,027 | 0.92% | 0.06% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 54,243 | $64,000 | 0.00% | 0.06% |
| PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 52,179 | $61,571 | 0.00% | 0.06% |
| MORGAN STANLEY | 11/14/2024 | 50,368 | $59,434 | -73.28% | 0.06% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 47,649 | $56,224 | 11.29% | 0.06% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 46,100 | $54,398 | -2.12% | 0.05% |
| XTX TOPCO LTD | 11/14/2024 | 43,664 | $51,524 | -27.93% | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 11/06/2024 | 41,458 | $48.92 M | -48.56% | 0.05% |
| LPL FINANCIAL LLC | 11/08/2024 | 38,315 | $45,212 | 5.51% | 0.05% |
| INVESCO LTD. | 11/12/2024 | 37,464 | $44,208 | 62.22% | 0.04% |
| US BANCORP \DE\ | 10/28/2024 | 33,792 | $39,875 | 100.00% | 0.04% |
| AJOVISTA, LLC | 11/12/2024 | 33,121 | $39.08 M | 100.00% | 0.04% |
| JANE STREET GROUP, LLC | 11/15/2024 | 27,231 | $32,132 | -65.83% | 0.03% |
| HRT FINANCIAL LP | 11/12/2024 | 26,840 | $31,000 | 100.00% | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 24,817 | $29,284 | 0.00% | 0.03% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 24,460 | $28,863 | -70.19% | 0.03% |
CytomX Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 104 institutional investors and hedge funds held shares of CytomX Therapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 7.81 M
BVF INC/IL: 5.23 M
VANGUARD GROUP INC: 5.16 M
JANUS HENDERSON GROUP PLC: 4.81 M
ACADIAN ASSET MANAGEMENT LLC: 3.1 M
Prosight Management, LP: 3.02 M
60.16% of CytomX Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 54.95 M shares in the last 24 months. This purchase volume represents approximately $58.79 M in transactions.